{"id":2818,"date":"2020-10-01T16:00:00","date_gmt":"2020-10-01T16:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/"},"modified":"2020-10-01T16:00:00","modified_gmt":"2020-10-01T16:00:00","slug":"xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/","title":{"rendered":"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V."},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har idag slutf\u00f6rt det f\u00f6rv\u00e4rv av samtliga aktier i det nederl\u00e4ndska medicintekniska f\u00f6retaget Organ Assist B.V. (\u201dOrgan Assist\u201d) som XVIVO offentliggjorde den 23 september 2020.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Den 23 september 2020 offentliggjorde XVIVO att bolaget ing\u00e5tt avtal om att f\u00f6rv\u00e4rva samtliga aktier i\u00a0Organ\u00a0Assist. Slutf\u00f6randet av f\u00f6rv\u00e4rvet var villkorat av att XVIVO erh\u00f6ll finansiering av k\u00f6peskillingen om h\u00f6gst 24 miljoner euro genom den nyemission av aktier som bolaget framg\u00e5ngsrikt genomf\u00f6rde senare samma dag. XVIVO har idag betalat den initiala kontanta k\u00f6peskillingen om 20 miljoner euro och slutf\u00f6rt f\u00f6rv\u00e4rvet av Organ Assist. Organ Assist kommer att d\u00e4rf\u00f6r konsolideras i XVIVO fr\u00e5n och med 1 oktober 2020.<br \/>\u00a0<br \/>Enligt aktie\u00f6verl\u00e5telseavtal kan tv\u00e5 till\u00e4ggsk\u00f6peskillingar om h\u00f6gst tv\u00e5 miljoner euro vardera komma att utg\u00e5, baserat p\u00e5 uppfyllelse av f\u00f6rs\u00e4ljningsm\u00e5l f\u00f6r 2021 respektive regulatoriskt godk\u00e4nnande i USA f\u00f6r Organ Assists njurmaskin.<br \/>\u00a0<br \/>F\u00f6r ytterligare information om f\u00f6rv\u00e4rvet och om Organ Assist, v\u00e4nligen se pressmeddelandet som XVIVO offentliggjorde den 23 september 2020.<br \/>\u00a0<br \/>G\u00f6teborg 1 oktober 2020<br \/>XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r ytterligare information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, VD, +46 31-788 21 50,\u00a0<a href=\"mailto:dag.andersson@xvivoperfusion.com\" target=\"_blank\" rel=\"nofollow noopener\">dag.andersson@xvivoperfusion.com<\/a><br \/>Christoffer Rosenblad, CFO, +46 73-519 21 59,\u00a0<a href=\"mailto:christoffer.rosenblad@xvivoperfusion.com\" target=\"_blank\" rel=\"nofollow noopener\">christoffer.rosenblad@xvivoperfusion.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">Om oss<\/strong><\/p>\n<hr\/>\n<p>XVIVO Perfusion AB \u00e4r ett medicinteknikbolag som utvecklar l\u00f6sningar och system f\u00f6r att bed\u00f6ma och bevara organ utanf\u00f6r kroppen, och f\u00f6r att selektera anv\u00e4ndbara organ och h\u00e5lla dem i optimal kondition i v\u00e4ntan p\u00e5 transplantation. XVIVO Perfusion AB har sitt huvudkontor i G\u00f6teborg och ytterligare kontor finns i Lund och i Denver, USA. XVIVO-aktien \u00e4r noterad p\u00e5 Nasdaq Stockholm och handlas under symbolen XVIVO. <br \/>Mer information finns att l\u00e4sa p\u00e5 hemsidan <a href=\"http:\/\/www.xvivoperfusion.com.\" target=\"_blank\" rel=\"nofollow noopener\">www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-pdf\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/0343fdb6-2ec6-45c1-a75d-702b3ec48e98\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v.pdf\" target=\"_blank\" rel=\"nofollow noopener\">XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V.<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har idag slutf\u00f6rt det f\u00f6rv\u00e4rv av samtliga aktier i det nederl\u00e4ndska medicintekniska f\u00f6retaget Organ Assist&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2818","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ca","mfn-news-tag-mfn-ca-ma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har idag slutf\u00f6rt det f\u00f6rv\u00e4rv av samtliga aktier i det nederl\u00e4ndska medicintekniska f\u00f6retaget Organ Assist...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\\\/\",\"name\":\"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-10-01T16:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO","og_description":"XVIVO Perfusion AB (publ) (\u201dXVIVO\u201d) har idag slutf\u00f6rt det f\u00f6rv\u00e4rv av samtliga aktier i det nederl\u00e4ndska medicintekniska f\u00f6retaget Organ Assist...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/","name":"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V. - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-10-01T16:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-slutfor-forvarvet-av-organ-assist-b-v\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO Perfusion slutf\u00f6r f\u00f6rv\u00e4rvet av Organ Assist B.V."}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}